Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NBT-NM108 for Hyperphagia in Prader-Willi Syndrome
NCT05541003Phase 2Completed
- Sponsor
- Rutgers University
- Start
- Jan 2023
- Primary completion
- May 2023
- Modality
- Microbiome Therapeutics, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of NBT-NM108 in Prader-Willi syndrome (PWS), obesity, sponsored by Rutgers University. Started Jan 2023; status: completed.
02
Drugs
NBT-NM108
03
Conditions
Prader-Willi syndrome (PWS)obesity
Beyond the preview
Go deeper on NCT05541003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05541003.